Global Specific IgE Blood Based Allergy Testing Market Growth (Status and Outlook) 2024-2030

Global Specific IgE Blood Based Allergy Testing Market Growth (Status and Outlook) 2024-2030

Specific IgE blood-based allergy testing is a diagnostic procedure used to detect the presence of immunoglobulin E (IgE) antibodies in the blood that are specific to particular allergens. This type of testing helps identify substances that trigger allergic reactions in individuals.

The global Specific IgE Blood Based Allergy Testing market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Specific IgE Blood Based Allergy Testing Industry Forecast” looks at past sales and reviews total world Specific IgE Blood Based Allergy Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Specific IgE Blood Based Allergy Testing sales for 2023 through 2029. With Specific IgE Blood Based Allergy Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Specific IgE Blood Based Allergy Testing industry.

This Insight Report provides a comprehensive analysis of the global Specific IgE Blood Based Allergy Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Specific IgE Blood Based Allergy Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Specific IgE Blood Based Allergy Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Specific IgE Blood Based Allergy Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Specific IgE Blood Based Allergy Testing.

United States market for Specific IgE Blood Based Allergy Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Specific IgE Blood Based Allergy Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Specific IgE Blood Based Allergy Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Specific IgE Blood Based Allergy Testing players cover Phadia (Thermo Fisher Scientific), Medwiss Analytic, Euroimmun, Quest Diagnostics, Eurofins Biomnis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Specific IgE Blood Based Allergy Testing market by product type, application, key players and key regions and countries.

Segmentation by Type:
ELISA
FEIA
Others

Segmentation by Application:
Hospitals
Clinics
Clinical Laboratories
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
ELISA
FEIA
Others

Segmentation by Application:
Hospitals
Clinics
Clinical Laboratories
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Phadia (Thermo Fisher Scientific)
Medwiss Analytic
Euroimmun
Quest Diagnostics
Eurofins Biomnis
Siemens Healthineers
Labcorp
Novartis
Omega Diagnostics
Minaris Medical America
MacroArray Diagnostics
DST
HYCOR Biomedical
Everlywell
Abionic
Diagnostic Solutions Laboratory
MosaicDX
Lifelab Testing
HOB Biotech Group
Shenzhen Biocup Biotech
Hangzhou Zheda Dixun Biological Gene Engineering
ACON Biotech

Please note: The report will take approximately 2 business days to prepare and deliver.